Julia Dan
Venture Partner @ Oxford Bioscience Partners
Julia Dan is a startup investor at Oxford Bioscience Partners. Julia Dan joined Oxford Bioscience Partners as a Venture Partner in 2013, bringing extensive experience of bridging the US and China markets in the healthcare industry. Most recently, Julia co-founded BGI Americas Corporation and brought BGI, a Chinese genomics sequencing service provider, into the US market. As Chief Executive Officer of BGIAmericas, Julia built a full staff and achieved positive returns within the first year of operations, and collaborated with leading pharmaceutical companies, including Merck, Pfizer, Novartis and Eli Lilly, etc..Prior to BGI Americas, Julia co-launched Sanofi-Genzyme’s operations in China, including managing a cross-functional team of eleven business units and functional groups, and supported the company’s acquisitions and licensing activities in the US and China. Before Genzyme, Julia had seven years of operational and management experience at China Construction Bank, the second largest bank in the world, including co-launching its operations in Germany.Julia holds a BA from Beijing Foreign Studies University China, an MBA from the Tuck School of Business at Dartmouth College, and an MPH from Harvard University School of Public Health.
Last updated:
For AI agents: llms.txt
About Oxford Bioscience Partners
Oxford Bioscience Partners (OBP), established in 1992, is a venture capital firm that provides equity financing and management assistance to emerging, entrepreneurial-driven companies within the life sciences and healthcare sectors. While willing to consider an investment in a company at almost any stage, OBP primarily works with early-stagesituations. With approximately $1B of committed capital under management, OBP has invested in over 140 life science companies worldwide.
Oxford Bioscience Partners Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Alan G. Walton
Senior General Partner
|
|||
|
Alan Watson
Executive-in-Residence
|
|||
|
Julia Dan
Venture Partner
|
|||
|
Manuel A. Navia
Executive-in-Residence
|
|||
|
Paul Tu
Venture Partner
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
FAQ
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!